Management of non-Hodgkin's lymphomas

16Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

The non-Hodgkin's lymphomas (NHL) are a heterogenous group of disorders characterised by malignant proliferation of lymphoid cells. The cellular origin is relatively well established with subtypes corresponding to the various stages of lymphocyte differentiation. The term encompasses a hotchpotch of conditions with very different morphological appearance, behaviour and clinical outcome. NHL comprise 2.4% of all cancers, with incidence increasing with age. The commonest presentation is with progressive lymphadenopathy, though extranodal manifestations are present in a significant proportion. The clinical behaviour ranges from a benign, indolent course to rapidly progressive disease; prognosis varies from weeks to many years. Treatment is correspondingly diverse, from 'watchful waiting' to high-dose chemotherapy with bone marrow stem cell transplantation. Cure is possible in an increasing number of patients and much interest currently lies in identifying patients with high-risk disease necessitating the use of intensive treatment regimens.

Author supplied keywords

References Powered by Scopus

A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group

6285Citations
N/AReaders
Get full text

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

0
5401Citations
N/AReaders
Get full text

National cancer institute sponsored study of classifications of non‐hodgkin's lymphomas. Summary and description of a working formulation for clinical usage

0
3469Citations
N/AReaders
Get full text

Cited by Powered by Scopus

iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma

28Citations
N/AReaders
Get full text

Cost-effectiveness analysis of the addition of rituximab to CHOP in young patients with good-prognosis diffuse large-B-cell lymphoma

26Citations
N/AReaders
Get full text

Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma

21Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Mounter, P. J., & Lennard, A. L. (1999). Management of non-Hodgkin’s lymphomas. Postgraduate Medical Journal, 75(879), 2–6. https://doi.org/10.1136/pgmj.75.879.2

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

83%

Researcher 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

54%

Chemistry 2

15%

Engineering 2

15%

Immunology and Microbiology 2

15%

Save time finding and organizing research with Mendeley

Sign up for free